The company’s latest report states that key drivers of the Russian healthcare market include improving regulatory guidelines and government initiatives
Breaking News
- Brexit – Implications For the Pharma Industry in Ireland The UK’s referendum decision to leave the EU in May 2016 undoubtedly sent shockwaves throughout Europe. European countries are still struggling to interpret what ‘Brexit’ will mean for them. Ireland,...
- EMA to Work With Stakeholders to Improve Product Information For EU Medicines The European Medicines Agency (EMA) has published an action plan to improve the product information (PI) for EU medicines, an information package for patients and healthcare professionals that accompanies every single medicine authorised in...
- Diaceutics Wins at Export Industry Awards Diaceutics, the Irish data insights and solutions company helping patients receive potentially lifesaving medicine through better testing, won the Small & Emerging Exporter of the Year Award at the recent Export...
- Brexit – Key Issues For the Pharmaceutical Industry Brexit – the stark reality is that the UK’s EU membership and the application of all EU legislation in the UK ends automatically at midnight on 30th March 2019! Current understanding...
- European Commission Diagnoses the State of Health in the EU Only by rethinking our health systems can we ensure that they remain fit-for-purpose and provide patient-centred care. This is what the 28 Country Health Profiles recently published by the Commission,...
The Irish division of Crowthorne Hi-Tec Services (CHTS) has joined forces with Biopharma Group to offer combined services throughout the whole
The joint venture will combine Sanofi’s biologics development pipeline with Lonza’s expertise to design, construct, start-up and operate a state-of-the-art
Big Pharma companies Pfizer, Sanofi and Johnson & Johnson were among the big investors last year in the Flanders region of
FDA’s Office of Generic Drugs (OGD) released their 2016 Annual Report on Feb. 24, 2017. The report details the office’s accomplishments
A mental health app, co-designed by the North East London Foundation Trust (NELFT) as well by young people, has won
The European Medicines Agency (EMA) announced on Feb. 24, 2017 that its Committee for Medicinal Products for Human Use (CHMP) has
Boston Scientific said on Thursday it was recalling a range of heart devices made at its Galway plant, sending the
Amgen announced that the European Commission (EC) has adopted a decision to change the Repatha (evolocumab) marketing authorization, approving a new
On Feb. 23, 2017, Novasep announced the opening of its new €11-million (approximately $11.64 million) bioconjugation unit in the
GlaxoSmithKline plc and Innoviva, Inc. announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were
Controlling robotic prostheses with one’s mind has been a hot topic in research, but making a prothesis ‘talk back’ has been
Distek, Inc., a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry, as well as an experienced
The University of Surrey has launched a new academic programme, aimed to help change the delivery of healthcare in the
The Austrian Centre of Industrial Biotechnology (acib) and GE Healthcare are introducing a cell line engineering research collaboration to bring
Jonathan Gardiner, packaging technologist at CDMO Almac looks at how packaging can become more efficient. The old adage, move with
Advertisements
